Insulin degludec and liraglutide Subcutaneous and Osimertinib Mesylate
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Osimertinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: osimertinib
Brand name: Tagrisso
Synonyms: Osimertinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Osmitrol
- Insulin degludec and liraglutide Subcutaneous-Osmolex ER
- Insulin degludec and liraglutide Subcutaneous-OsmoPrep
- Insulin degludec and liraglutide Subcutaneous-OsmoPrep Oral
- Insulin degludec and liraglutide Subcutaneous-Ospemifene
- Insulin degludec and liraglutide Subcutaneous-Osphena
- Osimertinib Mesylate-Insulin degludec Subcutaneous
- Osimertinib Mesylate-Insulin detemir
- Osimertinib Mesylate-Insulin Detemir (Cartridges and Prefilled Syringes)
- Osimertinib Mesylate-Insulin Detemir (Vials)
- Osimertinib Mesylate-Insulin detemir Subcutaneous
- Osimertinib Mesylate-Insulin glargine